ONTELIAN Trademark
ONTELIAN is a USPTO trademark filed by Pfizer Inc.. Status: Pending.
Trademark Facts
| Mark | ONTELIAN |
|---|---|
| Serial Number | 99808998 |
| Status | Pending |
| Filing Date | 2026-05-07 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Pfizer Inc. |
| Attorney of Record | Yana Gorbach |
| Prosecution Events | 3 |
| Latest Event | MAFR on 2026-05-07 |
Goods & Services
Class 005: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Recent Prosecution Activity
| Date | Code | Type | Description |
|---|---|---|---|
| 2026-05-07 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| 2026-05-07 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2026-05-07 | NWAP | I | NEW APPLICATION ENTERED |
Other Trademarks from Pfizer Inc.
Pfizer Inc. owns 5 USPTO trademarks (5 live).
- VOCINBEQ — Pending (filed 2026-05-11)
- LAGHENO — Pending (filed 2026-05-05)
- OPROVDA — Pending (filed 2026-05-05)
- AIM2 DISCOVERY CENTER — Pending (filed 2026-04-23)
- VEVADEQ — Pending (filed 2026-04-20)
Nice Class Context
- Class 005 (Pharmaceuticals) — 182960 live marks in this class